![Nymox Pharmaceutical Corp](/common/images/company/N_NYMX.png)
Nymox Pharmaceutical Corp (NYMX)
NASDAQ
Nymox Pharmaceutical Corp is a biopharmaceutical company focused on developing its drug candidate, NX-1207, for the treatment of BPH and the treatment of low-grade localized prostate cancer. Nymox Pharmaceutical Corp is a biopharmaceutical company focused on developing its drug candidate, NX-1207, for the treatment of BPH and the treatment of low-grade localized prostate cancer.
Period | Change | Change % | Open | High | Low | Avg. Daily Vol | VWAP | |
---|---|---|---|---|---|---|---|---|
1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | CS |
4 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | CS |
12 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | CS |
26 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | CS |
52 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | CS |
156 | -1.13 | -84.962406015 | 1.33 | 2.27 | 0.1688 | 199761 | 0.85974867 | CS |
260 | -1.5101 | -88.3047774984 | 1.7101 | 4.9 | 0.1688 | 199437 | 1.69711552 | CS |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.